Skip to content

Clinical trials

Terminated Phase 2/3 trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2/3 Status: Terminated Country / region: Norway Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20062
20091
20131
20151
20172
20211
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Oslo University Hospital4
Facet Biotech2
Boehringer Ingelheim1
Daiichi Sankyo1
Merck Sharp & Dohme LLC1
Nordlandssykehuset HF1
Norwegian University of Science and Technology1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Colitis, Ulcerative2
Anemia, Iron-Deficiency1
Atherosclerosis1
COVID-191
Carcinoma, Squamous Cell1
Clostridium Infections1
Communicable Diseases, Emerging1
Depression, Postpartum1
Hematoma, Subdural, Chronic1
Mesothelioma1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.